Tirzepatide patients lost an average of 20.2% of their body weight, while semaglutide patients lost 13.7%, a difference of 6.5 percentage points.[1] In practical terms, for someone starting at 250 pounds, that means losing roughly 50 pounds (22.8 kg) on tirzepatide versus 33 pounds (15.0 kg) on semaglutide.[1] Waist circumference shrank by an average of 7.2 inches (18.4 cm) with tirzepatide versus 5.1 inches (13.0 cm) with semaglutide, a difference with real implications for heart disease risk.[1] When researchers looked at more dramatic weight loss thresholds, tirzepatide pulled further ahead
Additionally, bariatric surgery is a one-and-done procedure, so maintenance, when coupled with lifestyle changes, is easier to accomplish, as the weight-reducing change is permanent
While research into the use of MT1 to treat these conditions is ongoing, results from phase II studies indicate that melanotan I holds promise
,
With the potential to enhance cognition and improve sleep, it adds an extra layer of health benefits